Copyright © 2000 by the European Society of Cardiology.
Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen
a Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark
b Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark
c Department of Internal Medicine, Hørsholm Hospital, Hørsholm, Denmark
Received April 11, 2000; accepted April 12, 2000
Abstract
Aims The present study was performed to evaluate pre-admission history, presentation, initial treatment and long-term mortality in patients with myocardial infarction and diabetes.
Methods and Results Between 1990 and 1992, 6676 patients with acute myocardial infarction were screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. In this cohort 719 (11%) of the patients had a history of diabetes. Among the diabetic patients 19% were treated with insulin, 52% with oral hypoglycaemic agents and 29% with diet only. The diabetic patients were slightly older, more likely to be female and had a higher prevalence of known cardiovascular disease. Even though the diabetic patients had the same frequency of ST-segment elevation on the electrocardiogram and the same admission delay, treatment with thrombolysis and aspirin was less frequently prescribed to the diabetic patients than to patients without diabetes. The mortality rate was significantly increased in the diabetic patients, 7-year mortality being 79% in insulin-treated, 73% in tablet-treated and 62% in diet-treated diabetic patients compared with 46% in patients without diabetes. In a multivariate analysis only diabetic patients treated with oral hypoglycaemic agents or with insulin had an increased mortality compared with non-diabetic patients.
Conclusions Patients with diabetes mellitus and myocardial infarction are treated with thrombolysis to a lesser extent than non-diabetic patients. Diabetic patients treated with oral hypoglycaemic agents or insulin, but not those treated with diet alone, have a significantly increased mortality following acute myocardial infarction compared with non-diabetic patients.
Key Words: Myocardial infarction, left ventricular function, mortality, thrombolysis, diabetes mellitus, oral hypoglycaemic agents
f1 Correspondence: Ida Gustafsson, MD, Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Nordre Fasanvej 57, DK-2000 Frederiksberg, Denmark.
References
- Kannel WB, McBee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation. 1979;59:813
[Abstract/Free Full Text] - Fuller I, Shipley M, Rose G. Mortality from coronary heart disease and stroke in relation to degree of hyperglycaemia: the Whitehall study. Br Med J. 1983;287:867870[ISI][Medline]
- Rytter L, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 1985;8:230234[Abstract]
- Letho S, Pyörälä K, Miettinen H. Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Int Med. 1994;236:291297[ISI][Medline]
- Madsen JK, Thomsen BL, Sørensen JN. Risk factors and prognosis after discharge for patients admitted because of suspected acute myocardial infarction with and without confirmed diagnosis. Am J Cardiol. 1987;59:10641070[CrossRef][ISI][Medline]
- Mak KH, Moliterno DJ, Granger CB. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol. 1997;30:171179[Abstract]
- Barbash GI, White HD, Modan M. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic agents. J Am Coll Cardiol. 1993;22:707713[Abstract]
- Granger CB, Calif RM, Young S. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol. 1993;22:920925
- Herlitz J, Malmberg K, Karlson BW. Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction. Acta Med Scand. 1988;224:3138[ISI][Medline]
- Am J Cardiol. 1994;73:44C50C[CrossRef][Medline]
- Køber L, Torp-Pedersen C, Carlsen JE. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:16701676
[Abstract/Free Full Text] - Køber L, Torp-Pedersen C, Carlsen J. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). Eur Heart J. 1994;15:16161620
[Abstract/Free Full Text] - McGovern PG, Pankow JS, Shahar E. Recent trends in acute coronary heart diseasemortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med. 1996;334:884890
[Abstract/Free Full Text] - Oswald GA, Corcoran S, Yudkin JS. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet. 1984;i:12641267
- Malmberg K, Rydén L, Efendic S. A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: effects on mortality. J Am Coll Cardiol. 1995;26:5765[Abstract]
- Melchior T, Gadsbøll N, Hildebrandt P. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction. Diabet Med. 1996;13:450456[CrossRef][ISI][Medline]
- Zuanetti G, Latini R, Maggioni AP. Influence of diabetes in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22:17881794[Abstract]
- Malmberg K, Herlitz J, Hjalmarson
. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large scale studies. Eur Heart J. 1989;10:423428[Abstract/Free Full Text] - Stone PH, Muller JE, Hartwell T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol. 1989;14:4957[Abstract]
- Lomuscio A, Preti R, Valenti D. Radionuclide assessment of cardiac function in diabetic patients after myocardial infarction. Acta Cardiol. 1988;1:3135
- Lomuscio A, Bestetti A, Vergani D. Radionuclide assessment of left ventricular function in patients with myocardial infarction and diabetes mellitus. J Intern Med. 1992;231:7376[ISI][Medline]
- Celentano A, Vaccaro O, Tammaro P. Early abnormalities of cardiac function in non-insulin dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol. 1995;76:11731176[CrossRef][ISI][Medline]
- Jaffe A, Spadaro J, Schechtman K. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J. 1984;108:3137[CrossRef][ISI][Medline]
- Hansen HHT, Kjærgaard SC, Bülow I. Thrombolytic therapy in diabetic patients with acute myocardial infarction. Diabetes Care. 1996;19:11351137[Abstract]
- Mahaffey KW, Granger CB, Toth CA. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. J Am Coll Cardiol. 1997;30:16061610[Abstract]
- Lancet. 1994;343:311322[CrossRef][ISI][Medline]
- Gustafsson I, Torp-Pedersen C, Køber L. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. J Am Coll Cardiol. 1999;34:8389
[Abstract/Free Full Text] - Kendall MJ, Lynch KP, Hjalmarson A. Beta-blockers and sudden cardiac death. Ann Intern Med. 1995;123:358367
[Abstract/Free Full Text] - Malmberg K, Rydén L, Hamsten A. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J. 1996;17:13371344
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
T. K. Schramm, G. H. Gislason, L. Kober, S. Rasmussen, J. N. Rasmussen, S. Z. Abildstrom, M. L. Hansen, F. Folke, P. Buch, M. Madsen, et al. Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People Circulation, April 15, 2008; 117(15): 1945 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grundy Diabetes and Coronary Risk Equivalency: What does it mean? Diabetes Care, February 1, 2006; 29(2): 457 - 460. [Full Text] [PDF] |
||||
![]() |
K. Malmberg, L. Ryden, H. Wedel, K. Birkeland, A. Bootsma, K. Dickstein, S. Efendic, M. Fisher, A. Hamsten, J. Herlitz, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur. Heart J., April 1, 2005; 26(7): 650 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kragelund, O. Snorgaard, L. Kober, B. Bengtsson, M. Ottesen, S. Hojberg, C. Olesen, J.-J. Kjaergaard, J. Carlsen, C. Torp-Petersen, et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients Eur. Heart J., November 1, 2004; 25(21): 1891 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Franklin, R. J. Goldberg, F. Spencer, W. Klein, A. Budaj, D. Brieger, M. Marre, P. G. Steg, N. Gowda, J. M. Gore, et al. Implications of Diabetes in Patients With Acute Coronary Syndromes: The Global Registry of Acute Coronary Events Arch Intern Med, July 12, 2004; 164(13): 1457 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Timmer, J. P. Ottervanger, K. Thomas, J. C.A Hoorntje, M.-J. de Boer, H. Suryapranata, F. Zijlstra, and on behalf of the Zwolle myocardial infarction stud Long-term, cause-specific mortality after myocardial infarction in diabetes Eur. Heart J., June 1, 2004; 25(11): 926 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J. Am. Coll. Cardiol., March 3, 2004; 43(5): 771 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Torp-Pedersen, C. Rask-Madsen, I. Gustafsson, F. Gustafsson, and L. Kober Diabetes mellitus and cardiovascular risk: just another risk factor? Eur. Heart J. Suppl., August 1, 2003; 5(suppl_F): F26 - F32. [Abstract] [PDF] |
||||
![]() |
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text] |
||||
![]() |
M. N. Zairis, S. S. Makrygiannis, O. A. Papadaki, A. G. Lyras, J. P. Kouzanidis, O. S. Ampartzidou, S. M. Handanis, S. M. Argyrakis, and S. G. Foussas Diabetes and ST Elevation Myocardial Infarction: How successful is intravenous thrombolysis for the diabetic heart? Diabetes Care, October 1, 2002; 25(10): 1890 - 1891. [Full Text] |
||||
![]() |
R. Moreno, E. Garcia, J. Zamorano, J.-L. Lopez-Sendon, and L. Sanchez-Harguindey Acute myocardial infarcation in diabetic patients. Are we acutally doing bad? Eur. Heart J., August 1, 2001; 22(15): 1359 - 1361. [Abstract] [PDF] |
||||
![]() |
I. Gustafsson, P. Hildebrandt, L. Kober, and C. Torp-Pedersen A reply Eur. Heart J., August 1, 2001; 22(15): 1361 - 1361. [Abstract] [PDF] |
||||
![]() |
I. Gustafsson and P. Hildebrandt Early Failure of the Diabetic Heart Diabetes Care, January 1, 2001; 24(1): 3 - 4. [Full Text] |
||||
![]() |
C.-K Wong and H.D White Dithering over the treatment of diabetics with acute myocardial infarction Eur. Heart J., December 1, 2000; 21(23): 1907 - 1909. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





